55.75
2.87 (5.43%)
| 前收盘价格 | 52.88 |
| 收盘价格 | 52.48 |
| 成交量 | 1,520,738 |
| 平均成交量 (3个月) | 1,391,311 |
| 市值 | 3,418,127,616 |
| 价格/销量 (P/S) | 5.03 |
| 股市价格/股市净资产 (P/B) | 3.87 |
| 52周波幅 | |
| 利润日期 | 4 May 2026 |
| 营业毛利率 | -54.98% |
| 营业利益率 (TTM) | -44.79% |
| 稀释每股收益 (EPS TTM) | -3.25 |
| 季度收入增长率 (YOY) | 23.20% |
| 总债务/股东权益 (D/E MRQ) | 18.25% |
| 流动比率 (MRQ) | 4.51 |
| 营业现金流 (OCF TTM) | -56.11 M |
| 杠杆自由现金流 (LFCF TTM) | -16.89 M |
| 资产报酬率 (ROA TTM) | -15.04% |
| 股东权益报酬率 (ROE TTM) | -38.22% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 看涨 | 看涨 |
| Diagnostics & Research (全球的) | 看涨 | 看涨 | |
| 股票 | Twist Bioscience Corporation | 看涨 | 看跌 |
AIStockmoo 评分
| 分析师共识 | -1.5 |
| 内部交易活动 | -5.0 |
| 价格波动 | -5.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 4.0 |
| 平均 | -1.50 |
|
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Core |
| 内部持股比例 | 1.98% |
| 机构持股比例 | 115.15% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 79.00 (Guggenheim, 41.70%) | 购买 |
| 中 | 51.00 (-8.52%) | |
| 低 | 43.00 (TD Cowen, -22.87%) | 购买 |
| 平均值 | 56.00 (0.45%) | |
| 总计 | 4 购买 | |
| 平均价格@调整类型 | 42.46 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Barclays | 03 Feb 2026 | 50.00 (-10.31%) | 购买 | 46.32 |
| 15 Dec 2025 | 39.00 (-30.04%) | 购买 | 31.07 | |
| Evercore ISI Group | 03 Feb 2026 | 52.00 (-6.73%) | 购买 | 46.32 |
| Guggenheim | 26 Jan 2026 | 79.00 (41.70%) | 购买 | 42.46 |
| TD Cowen | 08 Jan 2026 | 43.00 (-22.87%) | 购买 | 34.74 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| CHESS ROBERT | - | 49.11 | -2,184 | -107,256 |
| CHO DENNIS | - | 49.64 | -5,000 | -248,200 |
| FINN PATRICK JOHN | - | 49.88 | -74,217 | -3,899,727 |
| GREEN PAULA | - | 52.88 | -39,404 | -2,083,684 |
| LAPONIS ADAM | - | 47.66 | -7,000 | -333,620 |
| 累积净数量 | -127,805 | |||
| 累积净值 ($) | -6,672,487 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 49.85 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| FINN PATRICK JOHN | 职员 | 17 Feb 2026 | 自动卖出 (-) | 68,967 | 52.88 | 3,646,975 |
| FINN PATRICK JOHN | 职员 | 17 Feb 2026 | 执行期权 | 50,505 | - | - |
| GREEN PAULA | 职员 | 17 Feb 2026 | 卖 (-) | 39,404 | 52.88 | 2,083,684 |
| FINN PATRICK JOHN | 职员 | 13 Feb 2026 | 卖 (-) | 1,750 | 49.11 | 85,943 |
| FINN PATRICK JOHN | 职员 | 13 Feb 2026 | 执行期权 | 1,212 | - | - |
| CHESS ROBERT | 董事 | 13 Feb 2026 | 卖 (-) | 2,184 | 49.11 | 107,256 |
| LAPONIS ADAM | 职员 | 12 Feb 2026 | 自动卖出 (-) | 7,000 | 47.66 | 333,620 |
| FINN PATRICK JOHN | 职员 | 12 Feb 2026 | 卖 (-) | 3,500 | 47.66 | 166,810 |
| FINN PATRICK JOHN | 职员 | 12 Feb 2026 | 执行期权 | 2,500 | - | - |
| CHO DENNIS | 职员 | 11 Feb 2026 | 自动卖出 (-) | 5,000 | 49.64 | 248,200 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合